AKT-IN-22
AKT-IN-22 (compound 0R4) is a potent AKT allosteric inhibitor with anticancer effects.
For research use only. We do not sell to patients.
- CAS No.: 1313880-28-2
- Formula: C33H26FN7O2
- Molecular Weight:571.60
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | IC50 |
0.027 μM
Compound: 12j
|
Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis
Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis
|
[PMID: 22533986] |
| A2780 | IC50 |
0.032 μM
Compound: 12j
|
Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis
Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis
|
[PMID: 22533986] |
| A2780 | IC50 |
0.25 μM
Compound: 12j
|
Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis
Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis
|
[PMID: 22533986] |
| A2780 | IC50 |
2.2 μM
Compound: 12j
|
Antiproliferative activity against human A2780 cells after 72 hrs by MTS assay
Antiproliferative activity against human A2780 cells after 72 hrs by MTS assay
|
[PMID: 22533986] |
| AN3-CA | IC50 |
0.044 μM
Compound: 12j
|
Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis
Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis
|
[PMID: 22533986] |
| AN3-CA | IC50 |
0.045 μM
Compound: 12j
|
Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis
Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis
|
[PMID: 22533986] |
| AN3-CA | IC50 |
0.22 μM
Compound: 12j
|
Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis
Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis
|
[PMID: 22533986] |
| AN3-CA | IC50 |
2 μM
Compound: 12j
|
Antiproliferative activity against human AN3CA cells after 72 hrs by MTS assay
Antiproliferative activity against human AN3CA cells after 72 hrs by MTS assay
|
[PMID: 22533986] |
| Sf9 | IC50 |
0.005 μM
Compound: 12j
|
Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay
Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay
|
[PMID: 22533986] |
| Sf9 | IC50 |
0.018 μM
Compound: 12j
|
Inhibition of Akt2 (1 to 481) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay
Inhibition of Akt2 (1 to 481) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay
|
[PMID: 22533986] |
| Sf9 | IC50 |
0.17 μM
Compound: 12j
|
Inhibition of Akt3 (1 to 479) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay
Inhibition of Akt3 (1 to 479) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay
|
[PMID: 22533986] |
Chemical Information
-
CAS No. 1313880-28-2
-
Molecular Weight 571.60
-
Formula C33H26FN7O2
-
SMILES
O=C(C1=CC(F)=CC=C1)NCC2=CC=C(N3C4=C(N=C3C5=CC=CN=C5N)C=CC(C6=CC(NC(C)=O)=CC=C6)=N4)C=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)